Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2051
Friedman Industries
FRD
$304M
| $2.52M | ﹤0.01% |
499,619
+9,399
| +2% | +$43.3K |
2013 Q2
28 quarters
|
|
2052
MBIA
MBI
$225M
| $2.52M | ﹤0.01% |
347,492
-438,300
| -56% | -$3.18M |
2019 Q3
3 quarters
|
|
2053
Envela
ELA
$305M
| $2.52M | ﹤0.01% |
412,717
+192,623
| +88% | +$704K |
2019 Q4
2 quarters
|
|
|
GPL
2054
DELISTED
Great Panther Mining Limited
GPL
| $2.51M | ﹤0.01% |
502,337
+154,360
| +44% | +$683K |
2013 Q2
28 quarters
|
|
|
IO
2055
DELISTED
ION Geophysical Corporation
IO
| $2.51M | ﹤0.01% |
1,073,367
-24,030
| -2% | -$52.5K |
2013 Q2
28 quarters
|
|
|
SA
2056
Seabridge Gold
SA
$2.76B
| $2.51M | ﹤0.01% |
+143,162
| New | +$2.02M |
2020 Q2
0 quarters
|
|
2057
FMC
FMC
$1.28B
| $2.51M | ﹤0.01% |
+25,200
| New | +$2.33M |
2020 Q2
0 quarters
|
|
|
LBC
2058
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.5M | ﹤0.01% |
250,368
-3,100
| -1% | -$29.9K |
2019 Q1
5 quarters
|
|
|
CRHM
2059
DELISTED
CRH Medical Corporation
CRHM
| $2.5M | ﹤0.01% |
1,205,485
-348,500
| -22% | -$704K |
2016 Q1
17 quarters
|
|
2060
Peoples Financial Services
PFIS
$669M
| $2.5M | ﹤0.01% |
65,381
-14,500
| -18% | -$503K |
2015 Q3
19 quarters
|
|
2061
Arlo Technologies
ARLO
$1.28B
| $2.5M | ﹤0.01% |
967,230
+287,630
| +42% | +$695K |
2019 Q4
2 quarters
|
|
|
LEJU
2062
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
| $2.5M | ﹤0.01% |
136,315
+6,719
| +5% | +$118K |
2015 Q3
19 quarters
|
|
|
PRNB
2063
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.49M | ﹤0.01% |
41,700
-92,400
| -69% | -$5.71M |
2019 Q4
2 quarters
|
|
2064
Navient
NAVI
$858M
| $2.49M | ﹤0.01% |
+354,300
| New | +$2.64M |
2020 Q2
0 quarters
|
|
2065
DLH Holdings
DLHC
$59M
| $2.49M | ﹤0.01% |
339,168
+53,841
| +19% | +$337K |
2013 Q2
28 quarters
|
|
2066
Atlantic Union Bankshares
AUB
$5.27B
| $2.49M | ﹤0.01% |
107,394
-182,008
| -63% | -$4.1M |
2013 Q2
28 quarters
|
|
2067
DELISTED
OptiNose
OPTN
| $2.49M | ﹤0.01% |
22,280
+7,387
| +50% | +$526K |
2019 Q3
3 quarters
|
|
2068
Arcos Dorados Holdings
ARCO
$1.67B
| $2.48M | ﹤0.01% |
609,027
+30,335
| +5% | +$113K |
2019 Q4
2 quarters
|
|
2069
Coca-Cola Consolidated
COKE
$13.1B
| $2.48M | ﹤0.01% |
108,270
+89,270
| +470% | +$2.09M |
2020 Q1
1 quarter
|
|
2070
Cue Biopharma
CUE
$146M
| $2.48M | ﹤0.01% |
3,367
+687
| +26% | +$498K |
2019 Q4
2 quarters
|
|
|
TSC
2071
DELISTED
TriState Capital Holdings, Inc.
TSC
| $2.47M | ﹤0.01% |
157,100
-184,523
| -54% | -$2.51M |
2013 Q4
26 quarters
|
|
2072
Citizens
CIA
$168M
| $2.47M | ﹤0.01% |
411,800
-45,800
| -10% | -$263K |
2018 Q3
7 quarters
|
|
|
SRGA
2073
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.47M | ﹤0.01% |
25,859
-8,424
| -25% | -$628K |
2013 Q2
28 quarters
|
|
2074
Galicia Financial Group
GGAL
$5.88B
| $2.46M | ﹤0.01% |
+253,700
| New | +$2.17M |
2020 Q2
0 quarters
|
|
2075
DELISTED
scPharmaceuticals
SCPH
| $2.46M | ﹤0.01% |
333,686
+141,200
| +73% | +$1.24M |
2019 Q2
4 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.